These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10912302)

  • 1. Renal protection: progression, regression, remission from nephropathy beyond blood pressure control.
    Remuzzi G
    Int J Clin Pract Suppl; 2000 May; (110):9-15. PubMed ID: 10912302
    [No Abstract]   [Full Text] [Related]  

  • 2. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of ACE inhibitors and calcium channel blockers on the progression of renal failure.
    Zucchelli P; Zuccalà A; Gaggi R
    Nephrol Dial Transplant; 1995 Oct; 10 Suppl 9():46-51. PubMed ID: 8643208
    [No Abstract]   [Full Text] [Related]  

  • 4. Ramipril in the treatment of hypertension and proteinuria in children with chronic kidney diseases.
    Seeman T; Dusek J; Vondrák K; Flögelová H; Geier P; Janda J
    Am J Hypertens; 2004 May; 17(5 Pt 1):415-20. PubMed ID: 15110900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Further evidence for the renoprotective effect of ACE inhibitors: ramipril protects against the progression of chronic renal insufficiency in non-diabetic nephropathy with nephrotic proteinuria].
    Mayr M; Dickenmann MJ
    Schweiz Med Wochenschr; 2000 Apr; 130(13):491. PubMed ID: 10812646
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical use of evidence-based medicine: searching.
    Spier BJ; Feldstein DA
    WMJ; 2006 Jul; 105(5):9-11. PubMed ID: 16933405
    [No Abstract]   [Full Text] [Related]  

  • 7. Antihypertensive therapy in the presence of proteinuria.
    Sarafidis PA; Khosla N; Bakris GL
    Am J Kidney Dis; 2007 Jan; 49(1):12-26. PubMed ID: 17185142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACE inhibition and renal protection.
    Ritz E
    Clin Physiol Biochem; 1992; 9(3):94-7. PubMed ID: 1302163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How much must blood pressure be reduced in order to obtain the remission of chronic renal disease?
    Pisoni R; Remuzzi G
    J Nephrol; 2000; 13(3):228-31. PubMed ID: 10928301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is proteinuria reduction by angiotensin-converting enzyme inhibition enough to prove its role in renal protection in IgA nephropathy?
    Cattran DC
    J Am Soc Nephrol; 2007 Jun; 18(6):1633-4. PubMed ID: 17494880
    [No Abstract]   [Full Text] [Related]  

  • 11. [How to slow the progression of chronic renal insufficiency].
    Rossert J; Ronco P
    Rev Prat; 2001 Feb; 51(4):378-84. PubMed ID: 11355601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential hypertension and renal failure.
    Losito A
    Compr Ther; 1991 Feb; 17(2):20-5. PubMed ID: 1673652
    [No Abstract]   [Full Text] [Related]  

  • 13. Blood pressure, proteinuria and nephropathy in Fabry disease.
    Jain G; Warnock DG
    Nephron Clin Pract; 2011; 118(1):c43-8. PubMed ID: 21071972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achieving maximal renal protection in nondiabetic chronic renal disease.
    Taal MW; Brenner BM
    Am J Kidney Dis; 2001 Dec; 38(6):1365-71. PubMed ID: 11728976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. REIN on obesity, proteinuria and CKD.
    Choi ME
    J Am Soc Nephrol; 2011 Jun; 22(6):990-2. PubMed ID: 21617125
    [No Abstract]   [Full Text] [Related]  

  • 16. Importance of blood pressure control in chronic kidney disease.
    Ravera M; Re M; Deferrari L; Vettoretti S; Deferrari G
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S98-103. PubMed ID: 16565257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of prolonged angiotensin-converting enzyme inhibition on excretory kidney function and proteinuria in renal allograft recipients with chronic progressive transplant failure.
    Barnas U; Schmidt A; Haas M; Oberbauer R; Mayer G
    Nephrol Dial Transplant; 1996 Sep; 11(9):1822-4. PubMed ID: 8918629
    [No Abstract]   [Full Text] [Related]  

  • 18. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of chronic kidney disease: can it be prevented or arrested?
    Jaber BL; Madias NE
    Am J Med; 2005 Dec; 118(12):1323-30. PubMed ID: 16378772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive treatment and glomerular size selectivity in hypertensive patients with renal parenchymal disease and proteinuria.
    Shand BI; Lewis JG; Elder PA; Agarwal M
    Clin Nephrol; 2002 Oct; 58(4):321-4. PubMed ID: 12400851
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.